Analysed IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) News Sources
IDEAYA Biosciences and Servier Announce Positive Topline Results from Phase 2/3 Registrational Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA-A*02:01-Negative Metastatic Uveal Melanoma
13-04-2026
yahoo.com
IDEAYA Biosciences to Announce Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026
10-04-2026
yahoo.com
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer
06-04-2026
yahoo.com
Why IDEAYA Biosciences (IDYA) Is Up 7.5% After Early Data From First-in-Class Cancer Combo
04-04-2026
yahoo.com
A Look At IDEAYA Biosciences (IDYA) Valuation After New DLL3 Combo Trial Progress And Early Responses
03-04-2026
yahoo.com
Ideaya Biosciences Enrolls First Patient Evaluating Combination Therapy in Cancer Trial
30-03-2026
yahoo.com
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
30-03-2026
yahoo.com
What is the current price of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)?
The current price of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) is $34.52.
IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) absolute price change since previous trading day?
The absolute price change of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) since the previous trading day is $4.02.
IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) percentage price change since previous trading day?
The percentage price change of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) since the previous trading day is 13.1803%.
What is the most recent average sentiment score for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)?
The most recent average sentiment score for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)?
The most recent sentiment for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) is .
SEC-8K** Filing Available For IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.